Phyto Chem (I)

Why is Phyto Chem (India) Ltd falling/rising?

As of 16-Jul, Phyto Chem (India) Ltd's stock price is at Rs 23.77, down 3.45%, and has underperformed the sector. The stock is in a bearish trend, trading below all major moving averages, and has declined 16.45% year-to-date, significantly worse than the Sensex.

As of 16-Jul, Phyto Chem (India) Ltd's stock price is falling, currently at Rs 23.77, which represents a decrease of Rs 0.85 or 3.45%. The stock has underperformed compared to the sector, which has gained by 2.09%, indicating a relative weakness in its performance. Additionally, the stock has experienced a trend reversal, having fallen after two consecutive days of gains. <BR><BR>Today, the stock touched an intraday low of Rs 23.01, reflecting a significant drop of 6.54%. The trading activity shows that more volume was traded closer to this low price, suggesting that investors may be selling off their shares. Furthermore, Phyto Chem (India) Ltd is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. <BR><BR>In the context of broader market performance, the stock has seen a decline of 16.45% year-to-date, compared to a 9.43% decline in the Sensex, and a 21.16% drop over the past year, again worse than the Sensex's 6.59% decline. This overall negative performance, combined with the current day's underperformance and trend reversal, contributes to the stock's falling price.

Which are the latest news on Phyto Chem (I)?

How big is Phyto Chem (I)?

As of 10th June, Phyto Chem (India) Ltd has a market capitalization of 10.00 Cr and reported net sales of 9.06 Cr with a net loss of 1.80 Cr over the latest four quarters.

As of 10th June, <BR><BR>Market Cap: Phyto Chem (India) Ltd has a market capitalization of 10.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 9.06 Cr, while the sum of Net Profit for the same period reflects a loss of 1.80 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025, with Shareholder's Funds amounting to 6.39 Cr and Total Assets totaling 27.30 Cr.

Who are in the management team of Phyto Chem (I)?

The management team of Phyto Chem (I) includes Chairman P Sreemannarayana, Managing Director Y Nayudamma, and several directors, including independent and alternate directors, responsible for the company's strategic direction and regulatory compliance.

The management team of Phyto Chem (I) includes the following members:<BR><BR>1. **P Sreemannarayana** - Chairman (Non-Executive)<BR>2. **Y Nayudamma** - Managing Director<BR>3. **Y Venkateswarlu** - Director<BR>4. **P Anjaneyulu** - Director<BR>5. **Y Janaki Ramaiah** - Executive Director<BR>6. **Pavansingh Thakur** - Company Secretary & Compliance Officer<BR>7. **M Sreerama Murthy** - Independent Director<BR>8. **G S R Anjaneyulu** - Independent Director<BR>9. **Yugandhar Sampath Kumar Sakhamuri** - Independent Director<BR>10. **Vijitha Gorrepati** - Independent Director<BR>11. **K. Srinivasa Rao** - Alternate Director<BR>12. **N. Nagendra Naidu** - Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and ensuring compliance with regulations.

Who are the peers of the Phyto Chem (I)?

Phyto Chem (I) peers include Shivalik Rasayan, Bhaskar Agrochem, Aimco Pesticides, and others. In terms of performance, Bhaskar Agrochem leads with a 1-year return of 28.03%, while Phyto Chem (I) has a return of -19.85%.

Peers: The peers of Phyto Chem (I) are Shivalik Rasayan, Bhaskar Agrochem, Aimco Pesticides, Super Crop Safe, Adarsh Plant, Dhansa Labs, Aristo Bio-Tech, and Crop Life Scienc.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shivalik Rasayan, while Average management risk is found at Aristo Bio-Tech and Crop Life Scienc, and the rest have Below Average management risk. Growth is Average at Bhaskar Agrochem and Aristo Bio-Tech, while Below Average growth is seen at Shivalik Rasayan, Aimco Pesticides, Super Crop Safe, Adarsh Plant, Dhansa Labs, and Phyto Chem (I), and the rest. Excellent capital structure is noted at Shivalik Rasayan, while Average capital structure is found at Aristo Bio-Tech and Crop Life Scienc, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: Bhaskar Agrochem has the highest 1-year return at 28.03%, while Shivalik Rasayan has the lowest at -55.51%, with Phyto Chem (I) having a 1-year return of -19.85%, which is better than Shivalik Rasayan but worse than Bhaskar Agrochem. Additionally, Dhansa Labs, Aristo Bio-Tech, and Crop Life Scienc have a six-month return of 0.00%.

What does Phyto Chem (I) do?

Phyto Chem (India) Ltd manufactures and markets pesticides for the agriculture sector and has a market cap of INR 10 Cr. As of March 2026, it reported net sales and profit of 0 Cr, with a debt-equity ratio of 2.75 and a return on equity of -33.58%.

Overview: <BR>Phyto Chem (India) Ltd is engaged in the manufacturing and marketing of pesticides for the agriculture sector and operates within the Micro Cap category in the Pesticides & Agrochemicals industry.<BR><BR>History: <BR>Phyto Chem (India) Ltd was established in January 1989. The latest quarterly results reported net sales and net profit of 0 Cr for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 10 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 29 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 2.75 <BR>Return on Equity: -33.58% <BR>Price to Book: 1.84<BR><BR>Contact Details: <BR>Address: Survey No 628 Temple Street, Jinnaram Mandal Bonthapally Medak Telangana : 502313 <BR>Tel: 91-8458-275236 <BR>Email: info@phytochemindia.com <BR>Website: http://www.phytochemindia.com

Should I buy, sell or hold Phyto Chem (India) Ltd?

Are Phyto Chem (India) Ltd latest results good or bad?

Phyto Chem (India) Ltd's latest results are concerning, showing a net loss of ₹0.28 crores for Q4 FY26, with revenue plummeting 84.25% year-over-year and 92.26% from the previous quarter. The company faces significant operational challenges, reflected in a negative operating margin and return on equity, indicating a negative outlook.

The latest results for Phyto Chem (India) Ltd are quite concerning. In the fourth quarter of FY26, the company reported a net loss of ₹0.28 crores, marking its fourth consecutive quarter of losses. Revenue has drastically declined to ₹0.23 crores, which represents an alarming 84.25% decrease compared to the same quarter last year and a staggering 92.26% drop from the previous quarter.<BR><BR>The operating margin is severely negative at -282.61%, indicating that the company's fixed costs far exceed its revenue generation capacity. Additionally, the return on equity (ROE) stands at -50.00%, reflecting significant capital destruction and raising serious questions about the sustainability of its business model.<BR><BR>Overall, these results paint a grim picture of a company in distress, struggling to maintain operational viability in a challenging market environment. The combination of collapsing revenue, mounting losses, and negative profitability metrics suggests that the outlook for Phyto Chem is quite negative at this time.

How has been the historical performance of Phyto Chem (I)?

Phyto Chem (I) has shown a declining trend in net sales and profitability, with net sales dropping from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25, resulting in significant losses and negative operating profit. The company's financial health has deteriorated, reflected in increasing losses and stagnant cash flow.

Answer:<BR>The historical performance of Phyto Chem (I) shows a declining trend in net sales and profitability over the years, with significant losses reported in the most recent fiscal year.<BR><BR>Breakdown:<BR>Phyto Chem (I) has experienced a consistent decline in net sales, dropping from 44.49 Cr in Mar'21 to just 14.08 Cr in Mar'25. This decline is mirrored in total operating income, which also fell from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25. The company's total expenditure has decreased from 42.28 Cr in Mar'21 to 15.42 Cr in Mar'25, yet it remains higher than the operating income, resulting in an operating profit (PBDIT) that has turned negative, reaching -1.34 Cr in Mar'25. Profit before tax has similarly worsened, moving from a profit of 0.47 Cr in Mar'21 to a loss of 1.05 Cr in Mar'25, leading to a profit after tax of -0.99 Cr for the same period. The earnings per share have also deteriorated, showing a loss of -2.3 in Mar'25 compared to a profit of 1.14 in Mar'21. On the balance sheet, total liabilities have decreased from 67.59 Cr in Mar'20 to 27.30 Cr in Mar'25, while total assets have similarly declined from 67.59 Cr to 27.30 Cr over the same period. The company has reported no cash inflow or outflow in recent years, indicating a stagnant cash position. Overall, Phyto Chem (I) has faced significant challenges, reflected in its declining sales, increasing losses, and deteriorating financial health.

When is the next results date for Phyto Chem (I)?

Phyto Chem (I) will announce its results on 14 November 2025.

Phyto Chem (I) will declare its results on 14 November 2025.

Is Phyto Chem (I) overvalued or undervalued?

As of May 30, 2024, Phyto Chem (I) is considered risky and overvalued, with poor financial ratios indicating negative earnings performance and significant underperformance compared to industry peers and the Sensex.

As of 30 May 2024, the valuation grade for Phyto Chem (I) has moved from attractive to risky, indicating a significant deterioration in its financial standing. The company is currently assessed as overvalued. Key ratios reveal a PE ratio of -12.21, an EV to EBITDA of -22.40, and a ROE of -13.59%, all of which suggest poor profitability and negative earnings performance.<BR><BR>In comparison to its peers, Phyto Chem (I) stands out unfavorably; for instance, P I Industries has a PE ratio of 35.59, while UPL boasts a PE ratio of 38.74, both indicating a much stronger valuation. The negative ratios and the shift in valuation grade highlight that Phyto Chem (I) is not only underperforming relative to its industry peers but also reflects a concerning trend in its financial health. Additionally, the company's stock has underperformed the Sensex over various time frames, including a year-to-date decline of 17.85% compared to the Sensex's gain of 5.63%.

What is the technical trend for Phyto Chem (I)?

As of May 27, 2025, Phyto Chem (I) has a bearish technical trend, supported by negative MACD indicators and moving averages, while the RSI shows no momentum and Dow Theory indicates no clear trend.

As of 27 May 2025, the technical trend for Phyto Chem (I) has changed from mildly bearish to bearish. The weekly and monthly MACD indicators are both bearish, reinforcing the negative sentiment. The daily moving averages also indicate a bearish stance. Although the Bollinger Bands show a mildly bearish trend on both weekly and monthly time frames, the KST is bearish as well. The RSI shows no signal, indicating a lack of momentum in either direction. Dow Theory confirms no trend on both weekly and monthly levels. Overall, the current technical stance is bearish with a moderate strength, driven primarily by the bearish MACD and moving averages.

Who are the top shareholders of the Phyto Chem (I)?

The top shareholder of Phyto Chem (I) is promoter Nayudamma Yarlagadda, holding 7.87%. Individual investors own 49.29% of the shares, with no pledged promoter holdings or foreign institutional investors involved.

The top shareholders of Phyto Chem (I) include Nayudamma Yarlagadda, who is the promoter with the highest holding at 7.87%. The majority of the shareholding is held by individual investors, accounting for 49.29% of the shares. There are no pledged promoter holdings, and the company has no foreign institutional investors (FIIs) involved. Additionally, two mutual fund schemes hold a small portion of shares, totaling 0.19%.

Has Phyto Chem (I) declared dividend?

Phyto Chem (India) Ltd has declared a 10% dividend, amounting to ₹1.00 per share, with an ex-date of September 25, 2014. However, the dividend yield is 0%, and total returns over recent periods have been largely negative, except for the 3-year and 4-year spans.

Phyto Chem (India) Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1.0000<BR>- Ex-date: 25 Sep 14<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -22.7%, the dividend return was 0%, resulting in a total return of -22.7%.<BR><BR>For the 1-year period, the price return was -8.67%, the dividend return was 0%, leading to a total return of -8.67%.<BR><BR>Over the 2-year period, the price return was -21.4%, with a dividend return of 0%, resulting in a total return of -21.4%.<BR><BR>In the 3-year period, the price return was 29.15%, the dividend return was 0%, which resulted in a total return of 29.15%.<BR><BR>For the 4-year period, the price return was 22.81%, the dividend return was 0%, leading to a total return of 22.81%.<BR><BR>In the 5-year period, the price return was -4.81%, with a dividend return of 0%, resulting in a total return of -4.81%.<BR><BR>Overall, while Phyto Chem (India) Ltd has declared a dividend, the total returns over various periods show significant fluctuations, with negative returns in most periods except for the 3-year and 4-year spans. The dividend yield remains at 0%, indicating that the dividend has not contributed to the overall returns in recent years.